Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...
Low dose resulted in 89% median disabling seizure reduction in participants with MTS during the 7-12-month primary efficacy ...
An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced new experiences for enhancing and ...
Preclinical data showed enhanced anti-tumor activity and reduced cytokine release compared to conventional single-chain CAR T approaches -- Early clinical case from CELESTIAL-301 trial, the ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
Clinical Trials Arena on MSN
FDA cracks down on sponsor and researchers’ failure to publish trial data
The FDA has sent letters to more than 2,200 sponsors and investigators regarding more than 3,000 studies.
FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...
Health technology company Seqster announced Thursday the launch of its new 1-Click Sites platform, tapping BioIVT as its ...
The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, ...
In 2014, the European Medicines Agency (EMA) made headlines when it announced it would require pharmaceutical companies to report the results of their clinical trials. Now, in a new notice, EMA is ...
SEQSTER PDM, Inc. ("SEQSTER"), the leading healthcare technology company powering the connection, collection, and orchestration layer of patient health data, today launched 1-Clic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results